• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Proteomics approaches to long COVID: status and outlooks.

作者信息

Liang Xiao, Wang Yingrui, Guo Tiannan

机构信息

iMarker lab, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China.

Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China.

出版信息

Life Med. 2023 Jun 19;2(3):lnad023. doi: 10.1093/lifemedi/lnad023. eCollection 2023 Jun.

DOI:10.1093/lifemedi/lnad023
PMID:39872302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749077/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11749077/88857930b94b/lnad023_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11749077/88857930b94b/lnad023_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11749077/88857930b94b/lnad023_fig1.jpg

相似文献

1
Proteomics approaches to long COVID: status and outlooks.长新冠的蛋白质组学研究方法：现状与展望
Life Med. 2023 Jun 19;2(3):lnad023. doi: 10.1093/lifemedi/lnad023. eCollection 2023 Jun.
2
Is the Future Bright or Bleak? Assessing Past and Future Outlooks Across the Adult Lifespan.未来是光明还是黯淡？评估整个成年期的过去和未来前景。
Gerontol Geriatr Med. 2021 Sep 27;7:23337214211046080. doi: 10.1177/23337214211046080. eCollection 2021 Jan-Dec.
3
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning.利用靶向蛋白质组学和机器学习鉴定的长新冠器官和细胞特异性生物标志物。
Mol Med. 2023 Feb 21;29(1):26. doi: 10.1186/s10020-023-00610-z.
4
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks.在门诊环境中实施新冠肺炎的早期治疗：意大利一家三级护理中心面临的挑战及未来展望
Infect Dis Rep. 2022 Apr 25;14(3):315-320. doi: 10.3390/idr14030037.
5
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.蛋白质组学和信息学在理解 COVID-19 疾病的阶段和鉴定生物标志物中的应用。
J Proteome Res. 2020 Nov 6;19(11):4219-4232. doi: 10.1021/acs.jproteome.0c00326. Epub 2020 Jul 24.
6
Transcriptomics, proteomics, and metabolomics interventions prompt crop improvement against metal(loid) toxicity.转录组学、蛋白质组学和代谢组学干预措施促使作物针对金属（类）毒性进行改良。
Plant Cell Rep. 2024 Feb 27;43(3):80. doi: 10.1007/s00299-024-03153-7.
7
Multi-agent modelling of climate outlooks and food security on a community garden scheme in Limpopo, South Africa.南非林波波省一个社区花园计划中气候展望与粮食安全的多智能体建模
Philos Trans R Soc Lond B Biol Sci. 2005 Nov 29;360(1463):2183-94. doi: 10.1098/rstb.2005.1742.
8
Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.人支气管-肺蛋白质组学在 2019 年冠状病毒病（COVID-19）大流行中的应用和意义。
Expert Rev Proteomics. 2021 Nov;18(11):925-938. doi: 10.1080/14789450.2021.2010549. Epub 2021 Dec 19.
9
Health-related worries, self-image, and life outlooks of long-term survivors of childhood cancer.儿童癌症长期幸存者的健康相关担忧、自我形象和生活展望。
Health Soc Work. 2001 Nov;26(4):245-56. doi: 10.1093/hsw/26.4.245.
10
Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.基于质谱的蛋白质组学研究抗击 COVID-19：希望与挑战的专家综述。
OMICS. 2022 Jan;26(1):19-34. doi: 10.1089/omi.2021.0182. Epub 2022 Jan 7.

引用本文的文献

1
A single-cell transcriptomic atlas reveals senescence and inflammation in the post-tuberculosis human lung.单细胞转录组图谱揭示了肺结核后人类肺部的衰老和炎症。
Nat Microbiol. 2025 Jul 14. doi: 10.1038/s41564-025-02050-3.

本文引用的文献

1
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.血浆蛋白质组特征可预测 SARS-CoV-2 感染后哪些人会持续出现症状。
EBioMedicine. 2022 Nov;85:104293. doi: 10.1016/j.ebiom.2022.104293. Epub 2022 Sep 28.
2
Plasma biomarkers for systemic inflammation in COVID-19 survivors.COVID-19 幸存者全身炎症的血浆生物标志物。
Proteomics Clin Appl. 2022 Sep;16(5):e2200031. doi: 10.1002/prca.202200031. Epub 2022 Aug 15.
3
Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.
COVID-19 的多组学研究：在临床中发现那些看不见但被忽视的东西。
Cell Rep Med. 2022 Mar 15;3(3):100580. doi: 10.1016/j.xcrm.2022.100580.
4
Multiple early factors anticipate post-acute COVID-19 sequelae.多种早期因素预示着急性新冠病毒感染后会出现长期新冠症状。
Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25.
5
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.免疫蛋白质组学分析揭示了持续性 COVID-19 呼吸道疾病患者气道中异常的免疫细胞调节。
Immunity. 2022 Mar 8;55(3):542-556.e5. doi: 10.1016/j.immuni.2022.01.017. Epub 2022 Jan 26.
6
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
7
Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19.COVID-19 无症状期、有症状期和恢复期的免疫反应模式。
Biochim Biophys Acta Proteins Proteom. 2022 Feb 1;1870(2):140736. doi: 10.1016/j.bbapap.2021.140736. Epub 2021 Nov 11.
8
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.SARS-CoV-2 感染后急性后遗症的短期和长期发生率：系统评价。
JAMA Netw Open. 2021 Oct 1;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.
9
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.长期 COVID/COVID-19 后急性后遗症（PASC）中持续存在的凝血蛋白病理学伴随着抗纤溶酶水平的升高。
Cardiovasc Diabetol. 2021 Aug 23;20(1):172. doi: 10.1186/s12933-021-01359-7.
10
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.COVID-19 患者血清的蛋白质组学和代谢组学特征。
Cell. 2020 Jul 9;182(1):59-72.e15. doi: 10.1016/j.cell.2020.05.032. Epub 2020 May 28.